| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Phosphatidylinositol signaling system |
9 genes: DGKB, DGKH, ITPK1, ITPR1, ITPR2, PIK3C2A, PIK3CD, PIP5K1B, DGKI
|
5.205e-05 |
| Focal adhesion |
14 genes: COL6A1, FLNA, ITGA2, ITGA9, PIK3CD, PARVA, RAP1A, ACTB, ROCK1, VASP, ZYX, ACTN4, TLN2, ITGA10
|
0.0001421 |
| Cell adhesion molecules .CAMs. |
10 genes: CNTN1, CTLA4, CD274, HLA-DMB, HLA-DOA, HLA-DQA1, HLA-DQA2, HLA-F, ITGA9, CD6
|
0.0008521 |
| MAPK signaling pathway |
14 genes: GADD45A, DUSP5, FGFR2, MRAS, FLNA, NR4A1, FASLG, TAOK1, RAP1A, RASGRF2, SRF, TGFB2, MAPKAPK2, CACNA2D4
|
0.002523 |
| Intestinal immune network for IgA production |
5 genes: HLA-DMB, HLA-DOA, HLA-DQA1, HLA-DQA2, IL15
|
0.004294 |
| Ras signaling pathway |
12 genes: FGFR2, NGFR, HTR7, GNG2, RASGRF2, MRAS, RASAL3, PIK3CD, FASLG, PLA1A, RAP1A, ABL2
|
0.006147 |
| Neurotrophin signaling pathway |
8 genes: IRAK3, FASLG, NGFR, NTRK3, PIK3CD, RAP1A, YWHAH, MAPKAPK2
|
0.007005 |
| Phagosome |
9 genes: FCGR2A, HLA-DMB, HLA-DOA, HLA-DQA1, HLA-DQA2, HLA-F, ITGA2, ACTB, TUBA1A
|
0.007646 |
| Dorso.ventral axis formation |
3 genes: PIWIL4, NOTCH4, CPEB1
|
0.01688 |
| Notch signaling pathway |
4 genes: DTX1, RBPJ, NOTCH4, MAML2
|
0.01943 |
| Regulation of actin cytoskeleton |
10 genes: FGFR2, MRAS, ITGA2, ITGA9, PIK3CD, ACTB, ROCK1, ACTN4, PIP5K1B, ITGA10
|
0.02019 |
| Glycerolipid metabolism |
4 genes: DGKB, DGKH, ALDH7A1, DGKI
|
0.02384 |
| Antigen processing and presentation |
5 genes: HLA-DMB, HLA-DOA, HLA-DQA1, HLA-DQA2, HLA-F
|
0.02848 |
| Propanoate metabolism |
3 genes: ACACB, ALDH7A1, SUCLA2
|
0.03254 |
| Inositol phosphate metabolism |
4 genes: ITPK1, PIK3C2A, PIK3CD, PIP5K1B
|
0.03634 |
| Calcium signaling pathway |
8 genes: SLC25A4, HRH1, HRH2, HTR7, ITPR1, ITPR2, P2RX7, PDE1A
|
0.04198 |
| Leukocyte transendothelial migration |
6 genes: PIK3CD, RAP1A, ACTB, ROCK1, VASP, ACTN4
|
0.04431 |
| Gap junction |
5 genes: LPAR1, ITPR1, ITPR2, TJP1, TUBA1A
|
0.0481 |